RETN and osteosarcoma: In this study, CM from resistin-treated osteosarcoma cells enhanced EPC migration and tube formation (VEGF-A served as the positive control) (Figure 2C and 2D), indicating that EPCs may be recruited to the tumor microenvironment and form new blood vessels via resistin-promoted VEGF-A expression.